Thurs., Nov. 7, 2019 | 10:00-11:15 a.m. CT | Live MBHB Webinar via WebEx
Applicants who are drafting and prosecuting claims directed to life sciences inventions in the United States and Europe need to be cognizant of the written description and support requirements in the U.S. and Europe. Application of the written description requirement in the U.S. has, until recently, been somewhat more liberal than the stricter standard for showing written support in Europe. While the European standard has perhaps experienced some recent relaxation, the Federal Circuit’s decision in Amgen v. Sanofi (and other recent decisions), as well as the U.S. Patent and Trademark Office’s examination of applications for compliance with the written description requirement suggests that a more stringent approach may be taking hold in the U.S.
MBHB attorney and Patent Docs author Donald Zuhn, European patent attorney Charlotte Teall of Forresters, and MBHB attorney Nate Chongsiriwatana will discuss and compare compliance with the written description and support requirements in the U.S. and Europe for claims directed to life sciences inventions.
Presenter(s): MBHB attorney(s) Donald Zuhn, Jr., Ph.D. and Nathaniel Chongsiriwatana, Ph.D., and Forresters attorney Charlotte Teall
McDonnell Boehnen Hulbert & Berghoff LLP is committed to educating clients and friends of the firm with respect to significant developments and trends in the areas of intellectual property law.
NOTE: MCLE credit is not available for this archived recording.
